%0 Journal Article
%T Comparison of Quality of Life, Depression and Anxiety According to the Type of Treatment in Type 2 Diabetes
%A Soumaya Benmaamar
%A Houda Salhi
%A Ibtissam El Harch
%A Nada Lazar
%A Bineta Jho Diagne
%A Moncef Maiouak
%A Mohamed Berraho
%A Nabil Tachfouti
%A Hanan El Ouahabi
%A Samira El Fakir
%J Open Access Library Journal
%V 10
%N 4
%P 1-9
%@ 2333-9721
%D 2023
%I Open Access Library
%R 10.4236/oalib.1110062
%X The aim of this study was to compare the quality of life (QoL) and the prevalence of depression and anxiety in patients with type 2 diabetes mellitus according to the type of treatment: insulin, oral therapy or both therapies. A cross-sectional study that included adults with diabetes mellitus type 2 was conducted at Hassan II University Hospital in Fez, Morocco. Patients are divided into 3 groups: the anti-diabetic agents¡¯ group, the insulin therapy group and the combined therapy group. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety. A 12-Item Short-Form Health Survey questionnaire (SF-12) was employed to assess QoL. All statistical analyses were conducted using SPSS Version 26. A total of 176 diabetics with type 2 were included in the study: (61.9%) in the hypoglycemic drug group; (14.2%) in the insulin group and (23.9%) in both therapy groups. The mean age of the patients was 54.36 ¡À 10.18 years with a female predominance (60.8%). Our study showed a significant association between the scores of QoL (p < 0.05), the prevalence of depression (p = 0.03) and the type of therapy. A high prevalence of depression and poor QoL have been observed in patients on insulin therapy. Patients on insulin therapy have a high prevalence of depression and a more significant impairment of QoL. In fact, their evaluation must be integrated into the management of type 2 diabetics on insulin.
%K Diabetes Type 2
%K Type of Treatment
%K Insulin
%K Depression
%K Anxiety
%K Quality of Life
%U http://www.oalib.com/paper/6793401